Page last updated: 2024-11-04

suramin and Cancer of Skin

suramin has been researched along with Cancer of Skin in 2 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, K1
Pezen, DS1
Vogelzang, NJ1
Medenica, M1
Janisch, L1
Ratain, M1
Vokes, EE1
Soltani, K1
Kenner, JR1
Sperling, LC1
Waselenko, J1
Dawson, N1
Sau, P1
Moul, JW1

Other Studies

2 other studies available for suramin and Cancer of Skin

ArticleYear
Keratoacanthomas and skin neoplasms associated with suramin therapy.
    Archives of dermatology, 1996, Volume: 132, Issue:1

    Topics: Aged; Antineoplastic Agents; Humans; Keratoacanthoma; Male; Middle Aged; Skin Neoplasms; Suramin

1996
Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer.
    The Journal of urology, 1997, Volume: 158, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Drug Eruptions; Humans; Keratosis; Male; Prostatic Neop

1997